AI Analysis AI Analysis of KHTRF AI-Powered Market Insights
Stock Analysis PRO New!
Risk Assessment PRO New!
Trading Strategy PRO New!
Add KHTRF to Watchlist?
  • Easy Tracking In The Watchlist
PDF

Evaluation of Knight Therapeutics Inc. stock downgraded after the last trading session
(Updated on Jul 31, 2026)

SIGN UP FREE
or
Creating an account or logging in means you agree to StockInvest.us Terms of Use and Privacy Policy.
Buy or Hold candidate since Feb 23, 2026 Gain 48.75%

The Knight Therapeutics Inc. stock price gained 1.08% on the last trading day (Friday, 31st Jul 2026), rising from $6.95 to $7.03. During the last trading day the stock fluctuated 0% from a day low at $7.03 to a day high of $7.03. The price has risen in 5 of the last 10 days and is up by 0.21% over the past 2 weeks. Volume has increased on the last day along with the price, which is a positive technical sign, and, in total, 100 more shares were traded than the day before. In total, 100 shares were bought and sold for approximately $702.50 .

The stock lies in the middle of a wide and strong rising trend in the short term and a further rise within the trend is signaled. Given the current short-term trend, the stock is expected to rise 21.90% during the next 3 months and, with a 90% probability hold a price between $8.19 and $9.22 at the end of this 3-month period.

KHTRF Signals & Forecast

The Knight Therapeutics Inc. stock holds buy signals from both short and long-term Moving Averages giving a positive forecast for the stock. Also, there is a general buy signal from the relation between the two signals where the short-term average is above the long-term average. On corrections down, there will be some support from the lines at $6.93 and $6.87. A breakdown below any of these levels will issue sell signals. Knight Therapeutics Inc. has increased volume and follows the last lift in the price. This is considered to be a technical positive sign as volume should follow the price-formation. The very low volume increases the risk and reduces the other technical signals issued. Some negative signals were issued as well, and these may have some influence on the near short-term development. A sell signal was issued from a pivot top point on Wednesday, July 01, 2026, and so far it has fallen -0.99%. Further fall is indicated until a new bottom pivot has been found. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD).

Support, Risk & Stop-loss for Knight Therapeutics Inc. stock

Knight Therapeutics Inc. finds support from accumulated volume at $6.96 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

In general the stock tends to have very controlled movements and with good liquidity the risk is considered very low in this stock. During the last day, the stock moved $0 between high and low, or 0%. For the last week the stock has had daily average volatility of 0.174%.

Our recommended stop-loss: $6.75 (-3.90%) (This stock has very low daily movements and this gives very low risk. There is a sell signal from a pivot top found 21 days ago.)

Trading Expectations (KHTRF) For The Upcoming Trading Day Of Monday 3rd

For the upcoming trading day on Monday, 3rd we expect Knight Therapeutics Inc. to open at $7.03, and during the day (based on 14 day Average True Range), to move between $6.99 and $7.06, which gives a possible trading interval of +/-$0.0796 (+/-1.14%) up or down from last closing price. If Knight Therapeutics Inc. takes out the full calculated possible swing range there will be an estimated 1.14% move between the lowest and the highest trading price during the day.

Since the stock is closer to the resistance from accumulated volume at $7.03 (0.06%) than the support at $6.96 (0.93%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.

Earnings coming up

Knight Therapeutics Inc. will release earnings BMO on Thursday, August 06, 2026.The consensus among the analysts for the expected earnings (EPS) is $0.0100. We will update the financials statements for Knight Therapeutics Inc., that can be found here as soon as the records are public. Our systems has calculated a possible swing of +/- 1.30% in the first trading day after earnings release.

Is Knight Therapeutics Inc. stock A Buy?

Knight Therapeutics Inc. holds several positive signals, but we still don't find these to be enough for a buy candidate. At the current level, it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development. Due to some small weaknesses in the technical picture we have downgraded our analysis conclusion for this stock since the last evaluation from a Buy to a Hold candidate.

Current score: 0.000 Hold/Accumulate Downgraded

Zero in score indicates that our system is expecting high volatility and risk for the following trading day. Given the latest developments, we cannot determine the next direction as it may go both ways.

Predicted Fair Opening Price

Predicted fair opening price on August 3, 2026 - $7.03 ( 0.00000000000001%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker* eToro
*Your capital is at risk

KHTRF Performance

Trading levels for KHTRF

StockInvest.us
Full Access. No Commitment. 7 Days Free!
Long & Short-Term Golden Star Lists
AI Stock Analysis*
Top 10 Candidates on Every List
Premium Lists
Ad-FREE Browsing
Advanced Stock Screener

Fibonacci Support & Resistance Levels

Level Price
R3 7.03 0.00000000000001%
R2 7.03 0.00000000000001%
R1 7.03 0.00000000000001%
Price 7.03
S1 7.03 0.00000000000001%
S2 7.03 0.00000000000001%
S3 7.03 0.00000000000001%

Accumulated Volume Support & Resistance Levels

Level Price
R3 7.10 1.00%
R2 7.07 0.705%
R1 7.03 0.0569%
Price 7.03
S1 6.96 -0.93%
S2 6.59 -6.19%
S3 6.11 -13.02%

FAQ

What is the symbol for Knight Therapeutics Inc. Stock and on which exchange is it traded?
The symbol for Knight Therapeutics Inc. is KHTRF and it is traded on the PINK (Pink Sheets).

Should I buy or sell Knight Therapeutics Inc. Stock?
Knight Therapeutics Inc. holds several positive signals, but we still don't find these to be enough for a buy candidate. At the current level, it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development. Due to some small weaknesses in the technical picture we have downgraded our analysis conclusion for this stock since the last evaluation from a Buy to a Hold candidate.

How to buy Knight Therapeutics Inc. Stock?
Knight Therapeutics Inc. Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Knight Therapeutics Inc. Stock.

What's the current price of Knight Therapeutics Inc. Stock?
As of the end of day on the Jul 31, 2026, the price of an Knight Therapeutics Inc. (KHTRF) share was $7.03.

What is the 52-week high and low for Knight Therapeutics Inc. Stock?
The 52-week high for Knight Therapeutics Inc. Stock is $7.40 and the 52-week low is $4.07.

What is the market capitalization of Knight Therapeutics Inc. Stock?
As of the Jul 31, 2026, the market capitalization of Knight Therapeutics Inc. is 689.71M.

When is the next earnings date for Knight Therapeutics Inc.?
The upcoming earnings date for Knight Therapeutics Inc. is Aug 06, 2026.
Click to get the best stock tips daily for free!
ABOUT KNIGHT THERAPEUTICS INC.
Knight Therapeutics Inc., a specialty pharmaceutical company, develops, acquires, in-licenses, out-licenses, markets, and distributes pharmaceutical and consumer health products, and medical devices in Canada, Latin America, and internationally. It offers Nerlynx for extended adjuvant breast cancer and metastatic breast cancer; Tafasitamab for relapsed or refractory diffuse large B-cell lymphoma; Pemigatinib to treat metastatic cholangiocarcinoma...
GOLDEN STAR
Ticker Change Signal Date
FOX
$50.81
2.22% Jul 27
UNFI
$49.05
3.63% Jul 27
BIIB
$202.19
0.376% Jul 24
TSCO
$30.32
1.48% Jul 23
S
SW
$43.71
5.17% Jul 23

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE